PT Kalbe Farma Tbk. (PTKFF)

Market Cap	2.60B -25.5%
Revenue (ttm)	2.11B +8.3%
Net Income	219.41M +13.1%
EPS	0.00 +14.7%
Shares Out	n/a
PE Ratio	11.84
Forward PE	11.63
Dividend	0.00 (3.74%)
Ex-Dividend Date	Jun 4, 2025

Volume	1,680
Average Volume	22,022
Open	0.0590
Previous Close	0.0714
Day's Range	0.0590 - 0.0590
52-Week Range	0.0590 - 0.0958
Beta	-0.00
RSI	38.08
Earnings Date	Apr 2, 2026

About PT Kalbe Farma Tbk.

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the company pro...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1966
• Employees: 12,784
• Stock Exchange: OTCMKTS
• Ticker Symbol: PTKFF

Financial Performance

In 2025, PT Kalbe Farma Tbk.'s revenue was 35.32 trillion, an increase of 8.27% compared to the previous year's 32.63 trillion. Earnings were 3.66 trillion, an increase of 13.10%.

Financial numbers in IDR